Market Cap
₹61,887 Cr.
P/E
54.02
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics
Other Income
Other Income is not affecting ratios of the company
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Unable to calculate due to limited data
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Capex vs ROCE
ROCE of the company has increased over the last three years
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
Share price
Share price has increased over last 10 years due to earnings
ROE
Net Profit Margin is responsible for ROE increase over last 10 years
Working Capital
Working Capital of the company seems to be under control
Debt
Company should not have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a premium to 3 year historic valuations
ROE
Latest
29.78%
3yr Average
28.21%
5yr Average
26.29%
Net Profit Margin
Latest
17.75%
3yr Average
16.68%
5yr Average
15.35%
ROCE
Latest
38.7%
3yr Average
36.37%
5yr Average
34.73%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Market Share
0% (as of Jul 22)
Anti - Diabetes - Market Share
0.67% (as of Jul 22)
Anti-Infectives - Market Share
0.02% (as of Nov 20)
Antineo Plastic - Market Share
1.96% (as of May 19)
Blood Related - Market Share
0.32% (as of Jul 22)
Cardiovascular - Market Share
32.40% (as of Mar 19)
Creon - Market Share
0.61% (as of Nov 21)
Dermatology - Market Share
13.30% (as of Mar 19)
Digene - Market Share
13.90% (as of Mar 19)
Duphalac - Market Share
25.50% (as of Mar 19)
Duphaston - Market Share
13.36% (as of Nov 21)
Endocrinology - Market Share
7.85% (as of Jul 22)
Gastro-Intestinal - Market Share
5.35% (as of Nov 21)
Gynecology - Market Share
63.40% (as of Mar 19)
Influvac - Market Share
4.90% (as of Nov 21)
Neurological - Market Share
0.44% (as of Nov 21)
Pain - Market Share
6.20% (as of Dec 22)
Pharmaceutical Sector - Market Share
0.08% (as of Nov 21)
Respiratory - Market Share
0% (as of Jul 22)
Sex Stimulants - Market Share
0.02% (as of Apr 20)
Stomatological - Market Share
51.60% (as of Mar 19)
Thyronorm - Market Share
16.70% (as of Mar 19)
Udiliv - Market Share
1.81% (as of Jul 22)
Vaccines - Market Share
30.80% (as of Mar 19)
Vertin - Market Share
4.51% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Acute vs Chronic

Latest
|
locked
Historic

Dosage Form Break-Up

locked
Source
|
Latest
|
locked
Historic

Brand Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Brufen
    Cremaffin Plus
    Digene
    Duphalac
    Duphaston
    Thyronorm
    Zolfresh
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis